Tetanus toxoid - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe AUST R: 199742Active ingredients:
Meningococcal polysaccharide group A
Meningococcal polysaccharide group C
Meningococcal polysaccharide group W135
Meningococcal polysaccharide Group Y
Tetanus toxoid
Dosage form:
Injection, powder for
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
01 Nov 2026
to
30 Nov 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Unexpected increase in consumer demand
Management action:
Alternative brands are available. The sponsor has advised that stock will continue to be available for supply under the National Immunisation Program.
|